Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Lancet Healthy Longev. 2021 May 21;2(6):e317–e326. doi: 10.1016/S2666-7568(21)00086-6

Table. Vital status, age at death, and prevalence of outcomes in first-degree relatives, as reported by UK Biobank participants.

Father (median N=400 687*) Mother (median N=423 692*) Siblings (median N=361 816*)
Age at death, years, mean (SD) 70·9 (13·1) 75·7 (13·3) NA
Still alive 103 919/450 333 (23·1%) 180 472/454 999 (39·7%) NA
Alzheimer’s disease or dementia 19 255/399 793 (4·8%) 36 548/423 738 (8·6%) 2094/361 264 (0·6%)
Bowel cancer 23 883/399 920 (6·0%) 22 028/423 135 (5·2%) 8920/361 508 (2·5%)
Breast cancer NA 35 102/423 458 (8·3%) 16 586/361 809 (4·6%)
Chronic bronchitis or emphysema 46 263/402 389 (11·5%) 25 314/423 692 (6·0%) 10 325/361 823 (2·9%)
Diabetes 38 850/400 687 (9·7%) 40 091/423 892 (9·5%) 31 073/362 826 (8·6%)
Heart disease 133 320/407 557 (32·7%) 85 620/426 240 (20·1%) 37 858/363 542 (10·4%)
High blood pressure 91 242/402 899 (22·6%) 130 948/426 391 (30·7%) 77 059/364 661 (21·1%)
Lung cancer 37 443/401 624 (9·3%) 17 566/423 258 (4·2%) 8199/361 586 (2·3%)
Parkinson’s disease 10 106/399 089 (2·5%) 6998/422 464 (1·7%) 2005/361 199 (0·6%)
Prostate cancer 30 945/399 670 (7·7%) NA 5952/361 394 (1·6%)
Severe depression 15 430/399 499 (3·9%) 28 351/423 217 (6·7%) 26 368/362 315 (7·3%)
Stroke 62 810/402 616 (15·6%) 60 880/424 977 (14·3%) 12 031/361 925 (3·3%)

Data are % cases unless otherwise stated (numbers of cases and controls for each outcome are presented in appendix 1 table S4). NA=not applicable.

*

Value corresponds to the median number of UK Biobank participants reporting any outcome in fathers, mothers, or siblings (details are provided in appendix 1 table S4).

Age at death for fathers of 341 118 UK Biobank participants and mothers of 273 111 UK Biobank participants.